Streetwise Reports Examines Promising ‘Hot’ Alzheimer’s Market for Biotech with ‘Novel’ Drug Candidate – GlobeNewswire (press release)

November 23, 2017 by  
Filed under Alzheimers News

Sponsored By
Streetwise Reports Examines Promising 'Hot' Alzheimer's Market for Biotech with 'Novel' Drug Candidate
GlobeNewswire (press release)
ProMIS, Uddin continued, is developing PMN310 as a "novel Alzheimer's drug candidate based on a new amyloid beta theory—the disease is mainly caused by soluble toxic amyloid beta oligomers." Mackie expects at least two upcoming catalysts for ProMIS.

and more »

More Info: Click here

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

*